| RS1329070853 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1329101309 |
AMPD2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 9, Pontocerebellar hypoplasia type 9 |
| RS1329112134 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1329127252 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS1329127701 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1329129099 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1329133410 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS1329160503 |
PRR12
|
Health Risk |
Pathogenic |
complex microphthalmia, Neuroocular syndrome 1 |
| RS1329170892 |
PNPT1
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 13, Combined oxidative phosphorylation defect type 13 |
| RS1329201909 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1329226132 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1329227520 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1329228660 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1329240441 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1329255995 |
CLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1329261791 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1329285216 |
RBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, Congenital ocular coloboma |
| RS1329286555 |
IMPG1
|
Health Risk |
Pathogenic |
— |
| RS1329286592 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS1329301077 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1329322647 |
PDHA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase complex deficiency |
| RS1329331221 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1329359780 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1329360838 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1329394489 |
SNX14
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 20, Autosomal recessive spinocerebellar ataxia 20 |
| RS1329421967 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alstrom syndrome |
| RS1329424461 |
MTHFD1
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS1329427406 |
IL10RB
|
Health Risk |
Pathogenic/Likely pathogenic |
Inflammatory bowel disease 25, Inflammatory bowel disease 25 |
| RS1329438711 |
RICTOR
|
Health Risk |
Likely pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS1329440649 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Usher syndrome type 3A |
| RS1329445100 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1329461088 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cowden syndrome 1 |
| RS1329466833 |
TBCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Kenny-Caffey syndrome, Encephalopathy |
| RS1329479941 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1329481396 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1329504858 |
SMCHD1
|
Health Risk |
Pathogenic |
Scapulohumeral muscular dystrophy, Scapulohumeral muscular dystrophy |
| RS1329527659 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1329534393 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1329542100 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS1329552995 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Hepatocellular carcinoma |
| RS1329580446 |
POLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Telomere Biology Disorder, Telomere Biology Disorder |
| RS1329606728 |
USH1G
|
Health Risk |
Pathogenic |
— |
| RS1329610577 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS1329653090 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1329659775 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS1329661241 |
INVS
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Infantile nephronophthisis |
| RS1329664706 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1329683225 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1329710441 |
CYP27B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets, type 1A |
| RS1329724571 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1329745881 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS13297509 |
INPP5E
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 1, Joubert syndrome |
| RS1329751221 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1329751426 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS1329762657 |
ARCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1329771201 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1329826610 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1329836511 |
C6
|
Health Risk |
Pathogenic |
Complement component 6 deficiency, Complement component 6 deficiency |
| RS1329856696 |
IFT172
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS1329907808 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1329926209 |
B3GALT6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylodysplastic type |
| RS1329932861 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1329973329 |
FLNC
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1330009938 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1330017675 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1330021955 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1330043219 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, MYH9-related disorder |
| RS1330054460 |
MYT1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS1330065864 |
EFL1
|
Health Risk |
Likely pathogenic |
Shwachman-Diamond syndrome 2, Shwachman syndrome |
| RS1330089369 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1330094451 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 1 |
| RS1330106644 |
GORAB
|
Health Risk |
Pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS1330112951 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS1330115613 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1330118854 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1330131800 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1330135890 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1330180462 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1330220728 |
TECTA
|
Health Risk |
Pathogenic |
Monogenic hearing loss, Monogenic hearing loss |
| RS1330230723 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1330247874 |
TSHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hyperthyroidism due to mutations in TSH receptor, Hypothyroidism due to TSH receptor mutations |
| RS1330263985 |
CNGA3
|
Health Risk |
Likely pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1330306605 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1330309030 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1330332139 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS1330361513 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1330366594 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1330378388 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1330405287 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1330406146 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1330407036 |
HPS6
|
Health Risk |
Pathogenic |
— |
| RS1330413908 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Vanishing white matter disease |
| RS1330420689 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1330431481 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1330462697 |
IMPDH2
|
Health Risk |
Likely pathogenic |
Dystonic disorder, Dystonic disorder |
| RS1330485324 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia 2, Inborn genetic diseases |
| RS1330487131 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1330496818 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1330515772 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1330517530 |
FANCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group E, Inborn genetic diseases |